SUPN logo
SUPN NASDAQ US

Supernus Pharmaceuticals, Inc. - Common Stock

Healthcare · Pharmaceuticals Website · IPO Dec 2010
$50.48
▼ $-0.96 (-1.87%)
Vol 472K
7
Quality Score
fail
Mkt Cap
$2.8B
ROE
-1.8%
Margin
-2.8%
D/E
0.00
Beta
0.73
52W
$29–$58

Wall Street Consensus

12 analysts · Apr 2026
4
Strong Buy
6
Buy
2
Hold
0
Sell
0
Strong Sell
83.3%
Buy Rating

Price Chart

Similar Stocks

INDV
Indivior Pharmaceuticals, Inc
P/E 35.8
$4.5B
GPCR
Structure Therapeutics Inc
$4.2B
EWTX
Edgewise Therapeutics Inc
$2.6B
LQDA
Liquidia Corp
$3.0B
TARS
Tarsus Pharmaceuticals Inc
$3.5B
ALMS
Alumis Inc
$1.0B
AMRX
Amneal Pharmaceuticals Inc
P/E 671.4
$4.0B

Earnings

Beat rate: 100.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $0.35 $0.84 +$0.49
Sep 2025 $0.60 $1.01 +$0.41
Jun 2025 $0.48 $0.90 +$0.42
Mar 2025 $0.38 $0.44 +$0.06

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) 6.2% 6.2% 6.2% 6.2% -1.8% -1.8%
P/E (TTM) 27.36 36.51 41.55 47.93 — —
Net Margin 13.6% 9.7% 9.7% 9.7% -2.8% -2.8%
Gross Margin 89.8% 89.9% 89.9% 89.9% 89.9% 89.9%
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 2.58 2.58 2.58 2.58 1.80 1.80

Key Ratios

ROA (TTM)
-1.4%
P/S (TTM)
4.18
P/B
1.9
EPS (TTM)
$-0.34
CF/Share
$1.89
Rev Growth 3Y
+4.5%
52W High
$57.65
52W Low
$29.16
$29.16 52-Week Range $57.65

How does SUPN compare to Pharmaceuticals peers?

Peer group: Mid-cap Pharmaceuticals ($2B+) · 25 companies

SUPN AMRX AVDL AXSM AZN

SUPN valuation vs Pharmaceuticals peers

P/E ratio
—
▼ 0% below peers (30.7)
vs Peers
vs Industry
Fair value
P/S ratio
4.2
▼ 38% below peers (6.7)
vs Peers
vs Industry
Undervalued
P/B ratio
1.9
▼ 63% below peers (5.2)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (3.1%)
vs Peers
vs Industry
Low yield

SUPN profitability vs Pharmaceuticals peers

ROE
-1.8%
▲ 93% above peers (-26.1%)
vs Peers
vs Industry
Below avg
Net margin
-2.8%
▼ 93% below peers (-1.5%)
vs Peers
vs Industry
Weak
Gross margin
89.9%
▲ 1% above peers (88.9%)
vs Peers
vs Industry
In line
ROA
-1.4%
▲ 85% above peers (-9.5%)
vs Peers
vs Industry
Below avg

SUPN financial health vs Pharmaceuticals peers

D/E ratio
0.0
▼ 100% below peers (27.4)
vs Peers
vs Industry
Low debt
Current ratio
1.8
▼ 48% below peers (3.5)
vs Peers
vs Industry
Low liquidity
Beta
0.7
▲ 23% above peers (0.6)
vs Peers
vs Industry
More volatile

SUPN fundamentals radar

SUPN Peer median Industry

SUPN profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

SUPN vs peers: key metrics

Latest News

Supernus Pharma Insider Sells $5.4 Million as Stock Surges 53% in a …
Yahoo Finance · Mar 29